Gerold Bepler, MD
Enriched profileProfessor, Wayne State University · Wayne State University
Gerold Bepler is Professor, Wayne State University at Wayne State University. OpenAlex indexes 380 publications with 13,883 citations (h-index 59); ClinicalTrials.gov lists 6 registered studies with this person as an investigator.
Data verified 23 Oct 2026
Overview
Updated 23 Oct 2026
Gerold Bepler, MD, is Professor, Wayne State University. The public record shows 380 publications with 13,883 citations (h-index 59), centered on Lung Cancer Research Studies, Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment. It also documents an investigator role on 6 registered clinical trials, 6 NIH-funded awards (2009–2023).
- Top research focus: Lung Cancer Research Studies
- 6 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 23 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 176.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 23 Oct 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
Sponsor: Barbara Ann Karmanos Cancer Institute
- Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer
Sponsor: Barbara Ann Karmanos Cancer Institute
- Safety and Efficacy Study of Glufosfamide in Patients With Recurrent Sensitive Small Cell Lung Carcinoma
Sponsor: Threshold Pharmaceuticals
Industry payments
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
NIH funding
Updated 23 Oct 2026
6 NIH research awards on record, funded 2009–2023 per NIH RePORTER. The latest:
Congress activity
Updated 23 Oct 2026
57 congress contributions (2004–2025) across AACR, ASCO per OpenAlex. The most recent:
- Effect of elevated expression of LILRB4 and TSC22D3 on survival in lung cancer.
ASCO Annual Meeting
ASCO2025Co-author - Abstract 5900: ERBB2 alteration with or without co-existent EGFR mutation in metastatic non-small cell lung cancer
AACR (meeting unresolved)
AACR2020Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53
Cell Death and Disease
2020
Most-cited works
by citation count (OpenAlex)- 01
- 02Non–Small Cell Lung CancerArticle730 citations2010
- 03Screening for Lung CancerArticle601 citations2000
- 04DNA Synthesis and Repair Genes RRM1 and ERCC1 in Lung CancerArticle462 citations2007
- 05
Network
Updated 23 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 23 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/gerold-bepler-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 23 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- M.D.
Ph.D.
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →teamdraft.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mclaren.org ↗
Media & interviews
press, podcasts and appearances- Becker's Healthcare Podcast appearance
as president and CEO of Karmanos Cancer Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →karmanos.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Pranatharthi Chandrasekar, MD
Wayne State University
Eishi Asano, MD
Wayne State University
Bret Hughes, MD
Wayne State University
Mark Juzych, MD, MHSA
Wayne State University
Pasi Janne, MD, PhD
Dana-Farber Cancer Institute
Julie Brahmer, MD
Johns Hopkins University School of Medicine
Enriqueta Felip, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Funda Meric-Bernstam, MD
The University of Texas MD Anderson Cancer Center